There are numerous articles you can read about Oncotarget today, and most of them would not be able to tell you everything about it. In this article, we will conflate most of the pieces that you need to make sure that you can learn about what’s the latest thing about Oncotarget without wasting your time. Sure, most of what you read online is ethereal and will disappear after one reading. We will try to address that in this article. Shall we go on?
The Oncotarget Recap
One of the many articles you need to read from Oncotarget is the one about Genetic Polymorphisms in HLA-DP and its relationship with STAT4 nephropathy. In one of the most stellar research articles in ResearchGate, it is shown that Oncotarget was able to be the publishing journal who spread the information about the pathogenesis of IgA Nephropathy. In the ResearchGate article, it was shown that IgA nephropathy or (IgAN) can be initiated by what is now known as the Glomerular Deposition of Polymeric IgA1. Check Oncotarget at scimagojr.com
You can also see from the abstract of this article the information from Oncotarget that states how the new development in genetics and pathogenesis is able to find new ways to address the issues of diseases. It is also shown in the article that the local pathogens in one’s body could be related to the multilocus adaptation of the cells in one’s body.
It is also an added information from Oncotarget the statement that the perspective of the existing treatment options today in addressing kidney disease concerns should be able to find new affordable means. That should be the goal of medicine. This, fortunately, is what is driving Oncotarget to publish more journals. Watch this video on Youtube.
The EurekaAlert Article
Another interesting and relevant info you should learn, too, about Oncotarget is that it is one of the publishing firms that have found alternative therapies to thyroid cancer and other diseases. With EurekaAlert’s feature about Oncotarget’s research, it is now evident that Oncotarget is getting more relevant in its pursuit to fix all the necessary problems ingrained in the medical issues of curing thyroid cancer.